FDA Import Refusal 799-9492711-9/11/3 — AstraZeneca GmbH
The FDA refused shipment 799-9492711-9/11/3 from AstraZeneca GmbH (Germany) on Feb 23, 2024. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 23, 2024
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75